Biomedical Warming and Thawing Devices Market By Product (Manual, Automatic), By Sample Type (Blood Product, Stem cell, Embryo, Ovum, Others), By End User (Biotechnology and Pharmaceutical Companies, Hospitals and Diagnostic Laboratories, Blood Banks and stem cell banks): Global Opportunity Analysis and Industry Forecast, 2021-2031
The global biomedical warming and thawing devices market was valued at $159.3 million in 2021, and is projected to reach $376.7 million by 2031, registering a CAGR of 9.1% from 2022 to 2031. Biomedical warming and thawing devices are typically used to defrost samples of blood, tissues, cells, and other biologics. Cryopreservation is known as a method of successfully and safely preserving cells and tissues at a lower temperature, often below freezing point. It is therefore necessary to defrost these biological products before use, and in this case, biomedical warming and thawing equipment play a crucial role by assisting in the warming and defrosting of cryopreserved products.
They also reduce the possibility that cryo-preservative chemicals would harm these objects, as extended exposure to such chemicals might impair the preserved materials' living cells and other components. For stored cells to remain effective and viable for use in medical procedures, the use of biomedical warming and thawing devices is essential.
The biomedical warming and thawing devices market is anticipated to develop as more cryopreservation techniques are used to preserve cells and tissues. Increased demand for automated biomedical warming and thawing equipment is also helping the market grow. Growing need for pharmaceutical research is also anticipated to boost the rate of adoption for biomedical warming and thawing devices, thus, driving the market growth during the forecast period. The biomedical warming and thawing devices market is driven by rise in the number of blood banks and blood infusion centers, numerous advantages offered by automatic biomedical warming and thawing devices, and increase in the number of road accidents and trauma cases leading to blood transfusions. Biomedical warming and thawing devices are used in blood bank for preservation of plasma, stem cells, whole blood & RBCs (red blood cells), and platelets. Thus, increase in the number of blood banks and blood infusion centers is anticipated to drive the market growth.
Moreover, surge in demand for blood donation causes increase in the usage of warming and thawing devices for preservation of blood. Thus, this factor is anticipated to fuel the growth of the market. For instance, according to the World Health Organization, in 2020, globally, 118.5 million blood donations are collected each year. Around 85 million units of blood are given to patients each year. As per the same source, up to 54% of blood transfusions were given to children under 5 years of age in low-income countries; whereas, the most frequently transfused patient group was over 60 years of age, accounting for up to 75% of all transfusions in high-income countries.
Biomedical warming and thawing devices have a wide range of applications in pharmaceutical and biotechnology field for various research and studies, tissue culturing, and animal & plant engineering. Moreover, surge in number of patients for admission in medical emergency departments and rise in the number of road traffic accidents resulting in need of blood transfusion. Thus, these factors increase the demand for biomedical warming and thawing devices, which fuels the market growth. In addition, technological advancement in the healthcare sector and rise in R&D activities drive the growth of the biomedical warming and thawing devices market. On the other hand, strict regulation related to thawed biomedical products and samples and use of cryopreserved are anticipated to hinder the growth of the market. In addition, technical concerns, such as low survival biomaterial sample loss of cellular characteristics, altered gene expression, epigenic changes, and shift in protein composition are expected to limit the growth of the biomedical warming and thawing devices market.
The biomedical warming and thawing devices market is segmented on the basis of product, sample, end user, and region. On the basis of product, the market is segmented into manual and automatic. On the basis of sample market is segmented into blood products, stem cells, embryo, ovum, and others. Blood products is further bifurcated into plasma, & RBCs. By end user, the market is bifurcated into biotechnology & pharmaceutical companies, hospitals & diagnostic laboratories, and blood banks & stem cell banks. Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Some of the major companies that operate in the global biomedical warming and thawing devices market include, Barkey GmbH & co. kg, Boekel Scientific, Cardinal Health, Conroy Medical AB., Cytiva, CytoTherm, Eppendorf, Farrar Scientific, Fisher Scientific PTE LTD (Thermo Fisher Scientific), FreMon Scientific, Inc., GE, Helmer Scientific, KW Apparecchi Scientifici, Sarstedt AG & Co. KG, Sartorius AG, and Thaw World Medical Ltd.
Key Benefits For Stakeholders
This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the biomedical warming and thawing devices market analysis from 2021 to 2031 to identify the prevailing biomedical warming and thawing devices market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the biomedical warming and thawing devices market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global biomedical warming and thawing devices market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Product
Manual
Automatic
By Sample Type
Blood Product
Type
Plasma
RBC
Stem cell
Embryo
Ovum
Others
By End User
Hospitals and Diagnostic Laboratories
Biotechnology and Pharmaceutical Companies
Blood Banks and stem cell banks
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
Key Market Players
Barkey gmbh and co. kg
BioLife Solutions
BOEKEL SCIENTIFIC
CARDINAL HEALTH
Conroy Medical AB.
Cytiva
CytoTherm
Eppendorf
Farrar Scientific
FISHER SCIENTIFIC PTE LTD
FreMon Scientific, Inc.
Helmer Scientific
KW APPARECCHI SCIENTIFICI
Sarstedt AG and Co. KG
Sartorius AG
ThawWorld Medical Ltd.
General Electric Company
Please Note: It will take 7-10 business days to complete the report upon order confirmation.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook